Standout Papers

HOW CELLS RESPOND TO INTERFERONS 1998 2026 2007 2016 3.3k
  1. HOW CELLS RESPOND TO INTERFERONS (1998)
    George R. Stark, Ian M. Kerr et al. Annual Review of Biochemistry
  2. 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020)
    Thomas Unger, Claudio Borghi et al. Hypertension
  3. Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes (2006)
    Bryan Williams, Peter Lacy et al. Circulation
  4. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays (1998)
    Sandy D. Der, Aimin Zhou et al. Proceedings of the National Academy of Sciences
  5. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people (2014)
    Eleni Rapsomaniki, Adam Timmis et al. The Lancet
  6. Activation of the interferon system by short-interfering RNAs (2003)
    Michelle Holko, Michael J. de Veer et al. Nature Cell Biology
  7. Monitoring for conservation (2006)
    Jonathan M. Nichols, Bryan Williams Trends in Ecology & Evolution
  8. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon (1990)
    Éliane Meurs, Karen L. Chong et al. Cell
  9. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV (2004)
    Bryan Williams, N. Poulter et al. Journal of Human Hypertension
  10. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist (1998)
    Barry Bresnihan, Mark Cobby et al. Arthritis & Rheumatism
  11. Functional classification of interferon-stimulated genes identified using microarrays (2001)
    Michael J. de Veer, Michelle Holko et al. Journal of Leukocyte Biology
  12. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial (2015)
    Bryan Williams, Thomas M. MacDonald et al. The Lancet
  13. TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages (2002)
    Vladimir Y. Toshchakov, Bryan W. Jones et al. Nature Immunology
  14. Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes (2009)
    Toshiharu Ninomiya, Vlado Perkovic et al. Journal of the American Society of Nephrology
  15. 2020 International Society of Hypertension global hypertension practice guidelines (2020)
    Thomas Unger, Claudio Borghi et al. Journal of Hypertension
  16. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary (2004)
    Bryan Williams, Neil R Poulter et al. BMJ
  17. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. (1995)
    Y. Yang, Luiz F. L. Reis et al. The EMBO Journal
  18. Artificial intelligence in healthcare: transforming the practice of medicine (2021)
    Junaid Bajwa, Usman Munir et al. Future Healthcare Journal
  19. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials (2006)
    Heather O Dickinson, James Mason et al. Journal of Hypertension
  20. Essential hypertension (2007)
    Franz H. Messerli, Bryan Williams et al. The Lancet
  21. Central Blood Pressure Measurements and Antihypertensive Therapy (2007)
    Enrico Agabiti‐Rosei, Giuseppe Mancia et al. Hypertension
  22. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial (2019)
    Rajiv Agarwal, Patrick Rossignol et al. The Lancet
  23. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients (2023)
    Natalie Staplin, Alejandro de la Sierra et al. The Lancet

Immediate Impact

19 by Nobel laureates 56 from Science/Nature 134 standout
Sub-graph 1 of 19

Citing Papers

Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers
2022 StandoutNature
13 intermediate papers

Works of Bryan Williams being referenced

NF-κB Activation by Double-Stranded-RNA-Activated Protein Kinase (PKR) Is Mediated through NF-κB-Inducing Kinase and IκB Kinase
2000
JNK2 and IKKβ Are Required for Activating the Innate Response to Viral Infection
1999
and 9 more

Author Peers

Author Last Decade Papers Cites
Bryan Williams 17193 17729 14701 894 59.3k
Giuseppe Remuzzi 17583 15712 17561 1.3k 92.7k
Christian Weber 7817 22208 22205 1.1k 67.8k
Josef Penninger 7859 40322 17755 578 76.7k
Aldons J. Lusis 6133 30239 10413 615 62.5k
Russell Ross 13058 24997 17410 241 78.4k
Thomas F. Lüscher 27493 11328 5446 1.1k 61.0k
Takashi Kadowaki 7482 24742 5226 858 60.5k
Russell P. Tracy 22740 7792 7452 663 85.4k
Nader Rifai 20862 9021 8913 450 75.0k
Joseph Loscalzo 9839 17542 4071 601 53.7k

All Works

Loading papers...

Rankless by CCL
2026